scanX
Home
Medicamen Biotech

Medicamen Biotech

585.55
+17.25
(3.04%)
Market Cap (₹ Cr.)
₹723
52 Week High
729.60
Book Value
₹158
52 Week Low
355.45
PE Ratio
97.87
PB Ratio
3.49
PE for Sector
56.01
PB for Sector
19.89
ROE
7.62 %
ROCE
8.32 %
Dividend Yield
0.18 %
EPS
₹5.81
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
26.72 %
Net Income Growth
-35.54 %
Cash Flow Change
-7.15 %
ROE
-39.77 %
ROCE
-25.33 %
EBITDA Margin (Avg.)
-26.38 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
19
17
18
14
18
18
23
20
22
26
29
28
30
34
34
24
24
31
36
36
16
26
31
33
21
28
33
33
23
34
34
35
37
41
43
45
46
42
Expenses
18
17
17
15
15
15
20
17
19
22
24
23
26
29
28
20
20
26
30
30
14
22
25
28
15
21
26
26
18
27
28
28
30
33
37
39
38
37
EBITDA
1
1
2
-0
3
3
3
3
3
4
4
5
5
5
6
4
4
5
6
6
3
4
6
5
5
6
7
7
5
7
6
7
7
8
7
6
7
5
Operating Profit %
5 %
4 %
7 %
-3 %
19 %
13 %
12 %
14 %
15 %
15 %
13 %
17 %
13 %
13 %
13 %
18 %
18 %
16 %
16 %
15 %
10 %
15 %
18 %
16 %
24 %
22 %
19 %
19 %
22 %
17 %
17 %
17 %
18 %
18 %
14 %
13 %
15 %
12 %
Depreciation
1
0
0
0
0
0
0
0
1
0
1
1
1
0
0
1
1
1
1
1
1
1
1
1
0
1
1
2
2
2
2
2
2
2
2
2
2
2
Interest
1
1
1
1
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
2
1
Profit Before Tax
-0
-0
0
-2
2
1
1
2
2
3
3
3
4
5
5
4
4
4
5
5
2
3
5
4
5
5
5
5
3
4
4
4
5
5
4
4
4
3
Tax
-0
0
0
-0
0
0
0
0
0
1
1
1
2
1
2
1
1
1
2
1
1
1
1
1
0
1
1
2
1
1
1
1
1
1
1
1
1
1
Net Profit
0
-0
0
-1
2
1
1
2
1
3
3
3
2
3
4
2
2
3
4
4
1
2
3
3
4
4
4
4
3
4
4
4
4
4
3
3
3
2
EPS in ₹
0.01
-0.26
0.39
-1.47
1.83
1.14
1.16
1.66
1.10
2.28
2.42
2.49
1.66
2.75
3.05
2.06
2.06
2.75
3.18
3.05
1.20
1.72
2.64
2.47
3.39
3.40
3.46
3.09
2.25
2.94
2.85
2.97
3.25
3.49
2.38
2.19
2.45
1.78
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
69
60
73
118
137
176
192
226
277
294
Fixed Assets
20
19
19
25
24
34
90
92
92
91
Current Assets
49
41
53
91
96
97
92
121
158
152
Capital Work in Progress
0
0
0
0
15
41
0
0
0
0
Investments
0
0
0
0
0
2
2
2
4
8
Other Assets
49
41
54
92
97
100
100
131
180
195
Total Liabilities
51
42
47
43
50
54
58
78
83
85
Current Liabilities
45
37
43
41
49
50
50
71
80
82
Non Current Liabilities
7
5
4
2
1
4
8
7
3
3
Total Equity
17
18
27
75
87
122
134
148
194
209
Reserve & Surplus
8
8
16
63
75
110
122
136
181
196
Share Capital
10
10
11
12
12
12
12
12
13
13
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
0
0
20
-14
-6
1
1
17
-6
Investing Activities
0
-1
-2
-8
-15
-39
-18
-8
-8
-9
Operating Activities
-3
6
4
-5
4
12
13
5
-4
-0
Financing Activities
3
-5
-1
33
-4
21
6
4
28
3
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
44.83 %
44.83 %
44.83 %
43.60 %
43.60 %
43.60 %
43.21 %
43.21 %
43.21 %
43.21 %
43.21 %
43.21 %
43.21 %
42.99 %
FIIs
0.44 %
0.41 %
0.35 %
0.35 %
0.40 %
0.35 %
0.52 %
0.17 %
0.19 %
0.16 %
0.21 %
0.21 %
0.11 %
0.06 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.44 %
0.20 %
0.20 %
0.20 %
0.20 %
0.68 %
0.99 %
1.17 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
54.73 %
54.75 %
54.82 %
56.06 %
56.01 %
56.06 %
54.84 %
56.42 %
56.40 %
56.43 %
56.38 %
55.90 %
55.69 %
55.78 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,369.90 1,15,057.82 68.77 10,785.75 11.59 1,656 20.90 46.64
Ajanta Pharma
3,253.60 39,958.76 46.80 4,293.31 11.77 816 18.09 54.72
Gland Pharma
1,800.80 29,575.41 40.96 5,834.96 50.97 772 -25.94 37.78
Eris Lifesciences
1,324.25 18,099.35 47.59 2,032.96 19.85 397 -4.52 49.04
Caplin Point Laboratories
2,078.20 14,423.60 30.20 1,761.04 15.65 461 19.85 63.72
Marksans Pharma
300.15 13,511.08 40.45 2,227.83 16.55 315 26.45 61.73
Shilpa Medicare
835.70 7,954.80 193.68 1,159.77 8.64 32 1,091.53 54.53
Jeena Sikho Lifecare
1,562.10 3,826.60 114.61 207.35 40.06 34 - 64.84
Amrutanjan Health Care
795.15 2,358.67 55.39 192.42 12.50 21 -34.09 51.89
Hester Biosciences
2,444.90 2,079.38 107.44 315.18 12.07 21 11.62 47.56

Corporate Action

Technical Indicators

RSI(14)
Neutral
76.00
ATR(14)
Volatile
31.50
STOCH(9,6)
Neutral
75.40
STOCH RSI(14)
Overbought
91.57
MACD(12,26)
Bullish
13.71
ADX(14)
Strong Trend
37.79
UO(9)
Bearish
63.02
ROC(12)
Uptrend And Accelerating
24.78
WillR(14)
Overbought
-8.39
Bearish
3
Neutral
3
Bullish
3
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.